Administration of Neural Precursor Cells Ameliorates Renal Ischemia-Reperfusion Injury
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
20/10/2012
20/10/2012
2009
|
Resumo |
In this study we evaluated whether administration of stem cells of neural origin (neural precursor cells, NPCs) could be protective against renal ischemia-reperfusion injury (IRI). We hypothesized that stem cell outcomes are not tissue-specific and that NPCs can improve tissue damage through paracrine mechanisms, especially due to immunomodulation. To this end, Wistar rats (200-250 g) were submitted to 1-hour ischemia and treated with NPCs (4 x 10(6) cells/animal) at 4 h of reperfusion. To serve as controls, ischemic animals were treated with cerebellum homogenate harvested from adult rat brain. All groups were sacrificed at 24 h of reperfusion. NPCs were isolated from rat fetus telencephalon and cultured until neurosphere formation (7 days). Before administration, NPCs were labeled with carboxyfluorescein diacetate succinimydylester (CFSE). Kidneys were harvested for analysis of cytokine profile and macrophage infiltration. At 24 h, NPC treatment resulted in a significant reduction in serum creatinine (IRI + NPC 1.21 + 0.18 vs. IRI 3.33 + 0.14 and IRI + cerebellum 2.95 + 0.78mg/dl, p < 0.05) and acute tubular necrosis (IRI + NPC 46.0 + 2.4% vs. IRI 79.7 + 14.2%, p < 0.05). NPC-CFSE and glial fibrillary acidic protein (GFAP)-positive cells (astrocyte marker) were found exclusively in renal parenchyma, which also presented GFAP and SOX-2 (an embryonic neural stem cell marker) mRNA expression. NPC treatment resulted in lower renal proinflammatory IL1-beta and TNF-alpha expression and higher anti-inflammatory IL-4 and IL-10 transcription. NPC-treated animals also had less macrophage infiltration and decreased serum proinflammatory cytokines (IL-1 beta, TNF-alpha and INF-gamma). Our data suggested that NPC therapy improved renal function by influencing immunological responses. Copyright (C) 2009 S. Karger AG, Basel Ministério da Saúde MCT/CT-Saude/Decit/SCTIE/MS[552307/2005-0] Ministério da Saúde MCT/CT-Saude/Decit/SCTIE/MS Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)[04/08311-6] Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)[04/13826-5] Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)[05/50085-6] Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)[07/07139-3] |
Identificador |
NEPHRON EXPERIMENTAL NEPHROLOGY, v.112, n.1, p.E20-E28, 2009 1660-2129 http://producao.usp.br/handle/BDPI/28321 10.1159/000210575 |
Idioma(s) |
eng |
Publicador |
KARGER |
Relação |
Nephron Experimental Nephrology |
Direitos |
restrictedAccess Copyright KARGER |
Palavras-Chave | #Neurospheres #Neural precursor cells #Ischemia and reperfusion injury, renal #Immunomodulation #MESENCHYMAL STEM-CELLS #MARROW STROMAL CELLS #GROWTH-FACTOR #DIFFERENTIATION #TRANSPLANTATION #CEREBELLUM #FAILURE #ASTROCYTES #MIGRATION #SURVIVAL #Urology & Nephrology |
Tipo |
article original article publishedVersion |